Funding for this research was provided by:
Korea Centers for Disease Control and Prevention (2019-ER-7304-00, 2019-ER-7304-01)
Received: 27 November 2020
Accepted: 10 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This study has been registered at Clinical Research Information Service (KCT0005580). In addition, the study has been approved by the institutional review board of each participating center: the institutional review boards of Seoul National University College of Medicine/Seoul National University Hospital (H-1907-067-1047), Chonnam National University Hospital (CNUH-2019-276), Kangbuk Samsung Hospital (KBSMC 2019–07-029), Inje University Busan Paik Hospital (19–0151), Seoul Metropolitan Government Seoul National University Boramae Medical Center (30–2019-104), Hallym University Kangnam Sacred Heart Hospital (2019–07-015), Keimyung University Dongsan Hospital (DSMC 2019–07–055-008), and Seoul National University Bundang Hospital (B-1910/572–403). We will gather written informed consent from all the patients before enrollment. According to the good clinical practice guidelines and regional rules of the Institutional Review Board, we will collect informed consent from legally authorized representatives of pediatric patients if the patients are under the age of 6, and we will collect the form from both the patients and their legally authorized representatives when the patients are between 6 and 18. In the case when the family members are participating in the study by giving their blood samples, written informed consent will also be collected from the family members. We will also gather informed consent forms from the patients and their family members whose blood samples or DNA left over after genetic analysis will be sent to the National Biobank of Korea for public use.
: Not applicable.
: The authors declare that they have no competing interests.